These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36542691)

  • 1. A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
    Roehlen N; Saviano A; El Saghire H; Crouchet E; Nehme Z; Del Zompo F; Jühling F; Oudot MA; Durand SC; Duong FHT; Cherradi S; Gonzalez Motos V; Almeida N; Ponsolles C; Heydmann L; Ostyn T; Lallement A; Pessaux P; Felli E; Cavalli A; Sgrignani J; Thumann C; Koutsopoulos O; Fuchs BC; Hoshida Y; Hofmann M; Vyberg M; Viuff BM; Galsgaard ED; Elson G; Toso A; Meyer M; Iacone R; Schweighoffer T; Teixeira G; Moll S; De Vito C; Roskams T; Davidson I; Heide D; Heikenwälder M; Zeisel MB; Lupberger J; Mailly L; Schuster C; Baumert TF
    Sci Transl Med; 2022 Dec; 14(676):eabj4221. PubMed ID: 36542691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
    Roehlen N; Muller M; Nehme Z; Crouchet E; Jühling F; Del Zompo F; Cherradi S; Duong FHT; Almeida N; Saviano A; Fernández-Vaquero M; Riedl T; El Saghire H; Durand SC; Ponsolles C; Oudot MA; Martin R; Brignon N; Felli E; Pessaux P; Lallement A; Davidson I; Bandiera S; Thumann C; Marchand P; Moll S; Nicolay B; Bardeesy N; Hoshida Y; Heikenwälder M; Iacone R; Toso A; Meyer M; Elson G; Schweighoffer T; Teixeira G; Zeisel MB; Laquerriere P; Lupberger J; Schuster C; Mailly L; Baumert TF
    J Hepatol; 2023 Feb; 78(2):343-355. PubMed ID: 36309131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody targeting of claudin-1 as a potential colorectal cancer therapy.
    Cherradi S; Ayrolles-Torro A; Vezzo-Vié N; Gueguinou N; Denis V; Combes E; Boissière F; Busson M; Canterel-Thouennon L; Mollevi C; Pugnière M; Bibeau F; Ychou M; Martineau P; Gongora C; Del Rio M
    J Exp Clin Cancer Res; 2017 Jun; 36(1):89. PubMed ID: 28659146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape.
    Colpitts CC; Tawar RG; Mailly L; Thumann C; Heydmann L; Durand SC; Xiao F; Robinet E; Pessaux P; Zeisel MB; Baumert TF
    Gut; 2018 Apr; 67(4):736-745. PubMed ID: 28360099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Saviano A; Roehlen N; Baumert TF
    Semin Liver Dis; 2024 May; 44(2):180-190. PubMed ID: 38648796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
    Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
    J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of claudin 1, 3, and 4 during normal mammary gland development in the mouse.
    Blanchard AA; Watson PH; Shiu RP; Leygue E; Nistor A; Wong P; Myal Y
    DNA Cell Biol; 2006 Feb; 25(2):79-86. PubMed ID: 16460231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus receptor expression in normal and diseased liver tissue.
    Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
    Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
    Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
    J Virol; 2018 May; 92(10):. PubMed ID: 29491159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection.
    Mailly L; Wrensch F; Heydmann L; Fauvelle C; Brignon N; Zeisel MB; Pessaux P; Keck ZY; Schuster C; Fuerst TR; Foung SKH; Baumert TF
    Antiviral Res; 2019 Feb; 162():136-141. PubMed ID: 30599173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma.
    Chao YC; Pan SH; Yang SC; Yu SL; Che TF; Lin CW; Tsai MS; Chang GC; Wu CH; Wu YY; Lee YC; Hong TM; Yang PC
    Am J Respir Crit Care Med; 2009 Jan; 179(2):123-33. PubMed ID: 18787218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
    Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
    J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.
    Evans MJ; von Hahn T; Tscherne DM; Syder AJ; Panis M; Wölk B; Hatziioannou T; McKeating JA; Bieniasz PD; Rice CM
    Nature; 2007 Apr; 446(7137):801-5. PubMed ID: 17325668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tight junction dysfunction in the stratum granulosum leads to aberrant stratum corneum barrier function in claudin-1-deficient mice.
    Sugawara T; Iwamoto N; Akashi M; Kojima T; Hisatsune J; Sugai M; Furuse M
    J Dermatol Sci; 2013 Apr; 70(1):12-8. PubMed ID: 23433550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of anti-claudin-1 antibodies as candidate therapeutics against hepatitis C virus.
    Yamashita M; Iida M; Tada M; Shirasago Y; Fukasawa M; Nagase S; Watari A; Ishii-Watabe A; Yagi K; Kondoh M
    J Pharmacol Exp Ther; 2015 Apr; 353(1):112-8. PubMed ID: 25628391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody.
    Mailly L; Xiao F; Lupberger J; Wilson GK; Aubert P; Duong FHT; Calabrese D; Leboeuf C; Fofana I; Thumann C; Bandiera S; Lütgehetmann M; Volz T; Davis C; Harris HJ; Mee CJ; Girardi E; Chane-Woon-Ming B; Ericsson M; Fletcher N; Bartenschlager R; Pessaux P; Vercauteren K; Meuleman P; Villa P; Kaderali L; Pfeffer S; Heim MH; Neunlist M; Zeisel MB; Dandri M; McKeating JA; Robinet E; Baumert TF
    Nat Biotechnol; 2015 May; 33(5):549-554. PubMed ID: 25798937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis.
    Arabzadeh A; Troy TC; Turksen K
    BMC Cancer; 2007 Oct; 7():196. PubMed ID: 17945025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of a hepatitis C virus with altered entry factor requirements reveals a genetic interaction between the E1 glycoprotein and claudins.
    Hopcraft SE; Evans MJ
    Hepatology; 2015 Oct; 62(4):1059-69. PubMed ID: 25820616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.